Search

everythinglearnresearchcommunity

for

Search:↓

Telogen Effluvium is a common, usually reversible hair loss condition, often improved by removing the trigger and possibly treated with various products, though their effectiveness is uncertain.

The meeting highlighted the importance of genetic testing and multidisciplinary approaches in pediatric dermatology.

Low-level light therapy is FDA-approved for male pattern hair loss, increases hair count and strength, and is considered safe for use.

Dermatologists give better information on pathology forms, hypersensitivity vasculitis is a common skin issue, misdiagnoses can occur, and various skin conditions are linked to loss of elastin or genetic factors.

Alopecia areata in infants may be more common than previously thought.

Melatonin directly affects mouse hair follicles and may influence hair growth.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Scientists found a new, less invasive way to get stem cells from horse hair for veterinary medicine.

The new skin-targeted COVID-19 vaccine creates strong immune responses and could improve vaccination methods.

Nanotechnology shows promise for better drug delivery and cancer treatment.

New research is helping develop better treatments for alopecia areata.

The document concludes that there is a need for more research and regulation in dermatology, covering topics like latex allergy in children, the use of botulinum toxin, and treatments for skin conditions.

Finasteride and dutasteride increase sexual dysfunction reports.

Spironolactone safely and effectively treats hair loss in female scarring alopecia patients.

Systemic lupus erythematosus caused severe abdominal issues in a Sudanese woman.

Alopecia areata patients have higher levels of IL-6 and TNF-α.

TSLP affects atopic dermatitis by increasing sebum and reducing fat through IL-4/IL-13 signaling.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Methylprednisolone infusions can help some people with severe alopecia regrow hair.

New treatments focusing on immune pathways show promise for stubborn hair loss.

Trichoscopy helps tell apart Frontal Fibrosing Alopecia and Lichen planopilaris by showing different hair and scalp features.

Sequential therapy with dupilumab and baricitinib improved hair regrowth and atopic dermatitis in a child without adverse reactions.

Vemurafenib causes skin side effects similar to RASopathies, requiring regular skin checks and UVA protection.

Anti-TNF-α therapy may increase the risk of developing alopecia areata, especially in those with a history of autoimmune disease.

Infliximab may cause hair loss in Crohn's disease patients.

Sudden, unusual hair loss may indicate serious underlying health issues.

COVID-19 vaccines may rarely worsen hair loss in people with severe alopecia, but the benefits of vaccination still outweigh this risk.

Eating better, exercising, staying clean during periods, and learning about health can help reduce menstrual problems and improve life quality.

Intralesional Triamcinolone acetonide injections are safe and effective for treating alopecia areata.

The 675 nm laser effectively improved facial acne scars in dark skin with minimal side effects.